Status:
COMPLETED
Prospective Electroencephalography Evaluation of Sedation in COVID-19
Lead Sponsor:
Goethe University
Conditions:
Conscious Sedation
Pathologic Processes
Eligibility:
All Genders
18-80 years
Brief Summary
Sedation of severe COVID-19 disease are often complicated. We try to find a correlate for this observation by encephalographic studies.
Detailed Description
Sedation of critically ill ventilated coronavirus patients, continues to be a challenging issue. Also, neurological symptoms of severe COVID-19 disease have been described frequently. Difficulties in ...
Eligibility Criteria
Inclusion
- Intubated ventilated patients with SARS-CoV-2 associated acute respiratory distress syndrome and sedation difficulty.
Exclusion
- Pre-existing severe cerebral brain damage and dysfunction. For example: previous medial infarction, cerebral hemorrhage, structural epilepsy.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04815109
Start Date
April 1 2021
End Date
June 30 2022
Last Update
August 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany, 60590